Cargando…
Mesenchymal Stem Cells Engineered by Nonviral Vectors: A Powerful Tool in Cancer Gene Therapy
Due to their “tumor homing” and “immune privilege” characteristics, the use of mesenchymal stem cells (MSCs) has been proposed as a novel tool against cancer. MSCs are genetically engineered in vitro and then utilized to deliver tumoricidal agents, including prodrugs and bioactive molecules, to tumo...
Autores principales: | Ding, Yuan, Wang, Chenyang, Sun, Zhongquan, Wu, Yingsheng, You, Wanlu, Mao, Zhengwei, Wang, Weilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235299/ https://www.ncbi.nlm.nih.gov/pubmed/34205513 http://dx.doi.org/10.3390/pharmaceutics13060913 |
Ejemplares similares
-
BMP2 gene delivery to bone mesenchymal stem cell by chitosan-g-PEI nonviral vector
por: Yue, Jianhui, et al.
Publicado: (2015) -
Nonviral genome engineering of natural killer cells
por: Robbins, Gabrielle M., et al.
Publicado: (2021) -
Application of Peptides in Construction of Nonviral Vectors for Gene Delivery
por: Yang, Yujie, et al.
Publicado: (2022) -
Nonviral Gene Targeting at rDNA Locus of Human Mesenchymal Stem Cells
por: Hu, Youjin, et al.
Publicado: (2013) -
Systemic Sequential Therapy of CisGem, Tislelizumab, and Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma Conversion Therapy
por: Ding, Yuan, et al.
Publicado: (2021)